–
GT Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.5
FY22:
−21.3
FY23:
−13.6
FY24:
−14.4
FY25:
−12.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.5
FY22:
−21.0
FY23:
−12.8
FY24:
−14.0
FY25:
−0.73
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.0
FY22:
−20.9
FY23:
−7.60
FY24:
−13.2
FY25:
−28.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.0
FY22:
−20.9
FY23:
−7.60
FY24:
−13.2
FY25:
−28.4
All amounts in millions USD